Zymeworks Inc. (ZYME) Stock Price, News, Quote & History
Find the latest Zymeworks Inc. (ZYME) stock quote, history, news and other vital information to help you with your stock trading and investing.
Zymeworks Inc (ZYME) Q3 2024 Earnings Call Highlights: Strategic ...
2024年11月1日 · Zymeworks Inc (NASDAQ:ZYME) reported a net loss of $99.2 million for the nine months ended September 30, 2024, indicating ongoing financial challenges. Revenue decreased to $45.3 million for the ...
Zymeworks Inc (ZYME) Stock Price & News - Google Finance
Get the latest Zymeworks Inc (ZYME) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
ZYME Stock Quote Price and Forecast | CNN
View Zymeworks Inc. ZYME stock quote prices, financial information, real-time forecasts, and company news from CNN.
Zymeworks Inc. (ZYME) Stock Price, Quote & News - Stock Analysis
2024年10月30日 · Get a real-time Zymeworks Inc. (ZYME) stock price quote with breaking news, financials, statistics, charts and more.
Investor Relations | Zymeworks Inc.
2024年10月31日 · The Investor Relations website contains information about Zymeworks Inc.'s business for stockholders, potential investors, and financial analysts.
Zymeworks (ZYME) Stock Price, News & Analysis - MarketBeat
6 天之前 · Should You Buy or Sell Zymeworks Stock? Get The Latest ZYME Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.
Zymeworks Inc. Common Stock (ZYME) - Nasdaq
2024年7月6日 · Discover real-time Zymeworks Inc. Common Stock (ZYME) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
ZYME: Zymeworks Inc Stock Price Quote - NASDAQ GS - Bloomberg
2024年11月1日 · Stock analysis for Zymeworks Inc (ZYME:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Zymeworks: Turning The Tide With 2 Key Milestones For …
Zymeworks Inc. (NASDAQ:ZYME) is gearing up for a major inflection point in Q2 of 2025 because that is when its partners Jazz Pharmaceuticals and BeiGene are expected to release progression-free ...